StonvexLoading…
StonvexStonvexStonvexCore line items from RHI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.30B | $5.38B | $4.08B | $2.72B |
Operating Income | $36.91M | $76.46M | $54.01M | $40.42M |
Net Income | $13.79M | $132.99M | $101.23M | $40.97M |
EPS (Diluted) | $0.14 | $1.33 | $1.01 | $0.58 |
Total Assets | $2.70B | $2.86B | $2.85B | $2.83B |
Total Liabilities | $1.47B | $1.58B | $1.56B | $1.52B |
Cash & Equivalents | $278.39M | $464.44M | $365.29M | $380.55M |
Free Cash Flow OCF − CapEx | $-120.83M | $266.81M | $96.02M | $32.46M |
Shares Outstanding | 102.29M | 101.14M | 101.16M | 101.74M |